{"filing":{"accession_number":"0001628280-26-037735","cik":"0001077183","ticker":"NEO","company_name":"NEOGENOMICS INC","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"neo-20260521.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026037735/neo-20260521.htm"},"events":[{"id":10710,"run_id":9395,"accession_number":"0001628280-26-037735","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Stockholders voted at the Annual Meeting held on May 21, 2026, approving the election of nine directors, advisory approval of named executive officer compensation, an amendment to the 2023 Equity Incentive Plan increasing authorized shares by 5,000,000 shares, and ratification of Deloitte \u0026 Touche LLP as independent auditor.","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":7089,"accession_number":"0001628280-26-037735","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2023 Equity Incentive Plan increasing authorized shares by 5,000,000 shares. This is a compensatory arrangement amendment affecting the pool of equity available for executive and employee grants, which is a material disclosure under Item 5.02(e) and directly impacts future executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:57:43.017676+00:00","company_name":"","ticker":null,"filing_date":""},{"id":7090,"accession_number":"0001628280-26-037735","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from the Annual Meeting held on May 21, 2026. The filing reports voting outcomes for four proposals: election of nine directors, advisory approval of named executive officer compensation, approval of an amendment, and ratification of Deloitte \u0026 Touche LLP as independent auditor. The detailed vote tallies and percentages are the hallmark of shareholder_vote_results classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:57:43.017676+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7089,"accession_number":"0001628280-26-037735","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2023 Equity Incentive Plan increasing authorized shares by 5,000,000 shares. This is a compensatory arrangement amendment affecting the pool of equity available for executive and employee grants, which is a material disclosure under Item 5.02(e) and directly impacts future executive compensation capacity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:57:43.017676+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-05-22"},{"id":7090,"accession_number":"0001628280-26-037735","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder vote results from the Annual Meeting held on May 21, 2026. The filing reports voting outcomes for four proposals: election of nine directors, advisory approval of named executive officer compensation, approval of an amendment, and ratification of Deloitte \u0026 Touche LLP as independent auditor. The detailed vote tallies and percentages are the hallmark of shareholder_vote_results classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:57:43.017676+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-05-22"}]}